p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
Federica Giordano(University of Milano-Bicocca), Emanuela Grassilli(Link Campus University)
Cited by 34
Related Papers
Loss of MYC Confers Resistance to Doxorubicin-induced Apoptosis by Preventing the Activation of Multiple Serine Protease- and Caspase-mediated Pathways
|Journal of Biological Chemistry|2004|44